Precision Chemotherapy in Biliary Tract Cancer Moving From Empiric Intensification to Biomarker-Guided Treatment: Editorial on "Molecular Determinants of Outcome to Gemcitabine, Cisplatin, and Nab-Paclitaxel in Patients With Advanced BTC"

Authors

Sung Hwan Lee
Ahmed O Kaseb
Ju-Seog Lee

Publication Date

2-11-2026

Journal

Clinical and Molecular Hepatology

DOI

10.3350/cmh.2026.0179

PMID

41668290

Published Open-Access

yes

Recommended Citation

Sung Hwan Lee, Ahmed O Kaseb, and Ju-Seog Lee, "Precision Chemotherapy in Biliary Tract Cancer Moving From Empiric Intensification to Biomarker-Guided Treatment: Editorial on "Molecular Determinants of Outcome to Gemcitabine, Cisplatin, and Nab-Paclitaxel in Patients With Advanced BTC"" (2026). Faculty, Staff and Student Publications. 6056.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6056